OPKO Health Inc
NASDAQ:OPK

Watchlist Manager
OPKO Health Inc Logo
OPKO Health Inc
NASDAQ:OPK
Watchlist
Price: 1.52 USD -5% Market Closed
Market Cap: 1.1B USD
Have any thoughts about
OPKO Health Inc?
Write Note

Intrinsic Value

The intrinsic value of one OPK stock under the Base Case scenario is 1.57 USD. Compared to the current market price of 1.52 USD, OPKO Health Inc is Undervalued by 3%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

OPK Intrinsic Value
1.57 USD
Undervaluation 3%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
OPKO Health Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for OPK cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about OPK?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Biotechnology Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about OPKO Health Inc

Provide an overview of the primary business activities
of OPKO Health Inc.

What unique competitive advantages
does OPKO Health Inc hold over its rivals?

What risks and challenges
does OPKO Health Inc face in the near future?

Has there been any significant insider trading activity
in OPKO Health Inc recently?

Summarize the latest earnings call
of OPKO Health Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for OPKO Health Inc.

Provide P/S
for OPKO Health Inc.

Provide P/E
for OPKO Health Inc.

Provide P/OCF
for OPKO Health Inc.

Provide P/FCFE
for OPKO Health Inc.

Provide P/B
for OPKO Health Inc.

Provide EV/S
for OPKO Health Inc.

Provide EV/GP
for OPKO Health Inc.

Provide EV/EBITDA
for OPKO Health Inc.

Provide EV/EBIT
for OPKO Health Inc.

Provide EV/OCF
for OPKO Health Inc.

Provide EV/FCFF
for OPKO Health Inc.

Provide EV/IC
for OPKO Health Inc.

Show me price targets
for OPKO Health Inc made by professional analysts.

What are the Revenue projections
for OPKO Health Inc?

How accurate were the past Revenue estimates
for OPKO Health Inc?

What are the Net Income projections
for OPKO Health Inc?

How accurate were the past Net Income estimates
for OPKO Health Inc?

What are the EPS projections
for OPKO Health Inc?

How accurate were the past EPS estimates
for OPKO Health Inc?

What are the EBIT projections
for OPKO Health Inc?

How accurate were the past EBIT estimates
for OPKO Health Inc?

Compare the revenue forecasts
for OPKO Health Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of OPKO Health Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of OPKO Health Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of OPKO Health Inc compared to its peers.

Compare the P/E ratios
of OPKO Health Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing OPKO Health Inc with its peers.

Analyze the financial leverage
of OPKO Health Inc compared to its main competitors.

Show all profitability ratios
for OPKO Health Inc.

Provide ROE
for OPKO Health Inc.

Provide ROA
for OPKO Health Inc.

Provide ROIC
for OPKO Health Inc.

Provide ROCE
for OPKO Health Inc.

Provide Gross Margin
for OPKO Health Inc.

Provide Operating Margin
for OPKO Health Inc.

Provide Net Margin
for OPKO Health Inc.

Provide FCF Margin
for OPKO Health Inc.

Show all solvency ratios
for OPKO Health Inc.

Provide D/E Ratio
for OPKO Health Inc.

Provide D/A Ratio
for OPKO Health Inc.

Provide Interest Coverage Ratio
for OPKO Health Inc.

Provide Altman Z-Score Ratio
for OPKO Health Inc.

Provide Quick Ratio
for OPKO Health Inc.

Provide Current Ratio
for OPKO Health Inc.

Provide Cash Ratio
for OPKO Health Inc.

What is the historical Revenue growth
over the last 5 years for OPKO Health Inc?

What is the historical Net Income growth
over the last 5 years for OPKO Health Inc?

What is the current Free Cash Flow
of OPKO Health Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for OPKO Health Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
OPKO Health Inc

Current Assets 358m
Cash & Short-Term Investments 40.6m
Receivables 116m
Other Current Assets 201.4m
Non-Current Assets 1.6B
Long-Term Investments 101.5m
PP&E 128.4m
Intangibles 1.4B
Other Non-Current Assets 7.8m
Current Liabilities 219.6m
Accounts Payable 82.2m
Accrued Liabilities 98.6m
Other Current Liabilities 38.7m
Non-Current Liabilities 365m
Long-Term Debt 184.1m
Other Non-Current Liabilities 180.9m
Efficiency

Earnings Waterfall
OPKO Health Inc

Revenue
716.4m USD
Cost of Revenue
-530.2m USD
Gross Profit
186.1m USD
Operating Expenses
-452.7m USD
Operating Income
-266.6m USD
Other Expenses
23.5m USD
Net Income
-243.1m USD

Free Cash Flow Analysis
OPKO Health Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

For Q2 2024, OPKO Health reported a net loss of $10.3 million, improved from a $19.6 million loss in 2023. Diagnostic segment revenue grew 2% year-over-year to $129.4 million, while expenses dropped 9%, reducing the operating loss by 40%. The Pharmaceutical segment saw a drop in revenue to $52.8 million mainly due to a $90 million milestone payment in the prior year. Looking forward, OPKO expects Q3 gross profit share payments from Pfizer between $7 million and $9 million, and $15 million to $20 million for the second half of 2024. The Labcorp transaction is set to close by early October, anticipated to significantly aid in returning to profitability.

What is Earnings Call?
Fundamental Scores

OPK Profitability Score
Profitability Due Diligence

OPKO Health Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Negative Revenue Growth Forecast
Negative 1-Year Revenue Growth
Declining ROIC
19/100
Profitability
Score

OPKO Health Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

OPK Solvency Score
Solvency Due Diligence

OPKO Health Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
38/100
Solvency
Score

OPKO Health Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

OPK Price Targets Summary
OPKO Health Inc

Wall Street analysts forecast OPK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OPK is 4.04 USD with a low forecast of 2.02 USD and a high forecast of 8.93 USD.

Lowest
Price Target
2.02 USD
33% Upside
Average
Price Target
4.04 USD
166% Upside
Highest
Price Target
8.93 USD
487% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for OPK?

Click here to dive deeper.

Dividends

OPKO Health Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for OPK is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

OPK Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

OPKO Health Inc Logo
OPKO Health Inc

Country

United States of America

Industry

Biotechnology

Market Cap

1.1B USD

Dividend Yield

0%

Description

OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. The company is headquartered in Miami, Florida and currently employs 5,767 full-time employees. The Company’s segments include Diagnostics and Pharmaceutical. The Diagnostics segment consists of the clinical laboratory operations of Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations. Pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Through Bio-Reference, it operates laboratory divisions, such as Bio-Reference, GenPath (Oncology), GenPath (Women's Health) and GeneDx. Its Pharmaceutical Business have one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Renal Products, Oxyntomodulin, Biologics, Factor VIIa -CTP and hGH-CTP. The company also owns an active pharmaceutical ingredients (APIs) manufacturer in Israel through its subsidiary FineTech Pharmaceutical, Ltd.

Contact

FLORIDA
Miami
4400 Biscayne Blvd
+13055754181.0
www.opko.com

IPO

1995-11-02

Employees

5 767

Officers

See Also

Discover More
What is the Intrinsic Value of one OPK stock?

The intrinsic value of one OPK stock under the Base Case scenario is 1.57 USD.

Is OPK stock undervalued or overvalued?

Compared to the current market price of 1.52 USD, OPKO Health Inc is Undervalued by 3%.

Back to Top